Jiaren Sun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jiaren Sun has a total of 165 co-authors. Here are the top co-authors by number of shared publications:
- Yuejin Liang
Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA
18 shared publications Lynn Soong
Department of Microbiology and Immunology University of Texas Medical Branch Galveston TX USA
14 shared publicationsPanpan Yi
Department of Infectious Diseases, Key Laboratory of Viral Hepatitis of Hunan, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China
9 shared publicationsZuliang Jie
Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, TX, USA
9 shared publications- Lynn Soong
Department of Pathology, University of Texas Medical Branch, United States
8 shared publications Jiyang Cai
Department of Ophthalmology, University of Texas Medical Branch, Galveston, TX 77555, USA
6 shared publications
Latest Publications
- Open Access
- 23 April 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1791779
Differential spleen immune signatures and germinal center responses during acute infection with Orientia tsutsugamushi Karp versus Gilliam strains
Introduction: Scrub typhus is an emerging and neglected tropical disease caused by Orientia tsutsugamushi ( Ot ). Immunity in scrub typhus patients is known to be short-lived; however, its underlying mechanisms remain unclear. No reports have examined humoral immune signatures to clinically prevalent Ot strains. Methods: We compared two clinically relevant Ot strains, Karp and Gilliam, in a C57BL/6 murine model. Using equivalent infectious doses, we assessed splenic B cell and germinal center (GC) responses during acute infection through flow cytometry, immunohistology, serological analyses, and RNA sequencing. Results: Karp infection resulted in high tissue bacterium burdens and 50% mortality rates, whereas Gilliam infection was self-healing with limited bacterium dissemination and growth. Yet, Gilliam induced strong splenic B cell responses, as judged by total numbers of B cells, follicular B cells, and marginal zone B cells, which correlated with serum IgG and IgM levels. Given that Karp- but not Gilliam-infected spleens displayed GC disorganization/loss and MZ abrogation, we compared splenic RNAseq profiles. On day 4 post-infection, Karp induced significant elevation of transcriptional inflammatory signatures ( Ccl2 , Il33 , Ifng ) and inflammatory gene pathways ( Il1 , Il6 , Tnf , Ifng ), the characteristics of severe scrub typhus. Moreover, IPA analysis revealed Karp-induced neutrophil activation/degranulation and defense response pathways, which were in sharp contrast to Gilliam-induced upregulation of phagocytosis signaling pathways. Splenocyte flow cytometry confirmed significantly higher influx of activated phagocyte subsets (neutrophils, M1 macrophages, and inflammatory monocytes) during Karp infection than Gilliam infection, indicating greater infiltration of innate immune cells in severe scrub typhus. Discussion: Collectively, this study provides the first lines of evidence for Ot strain-related, cellular and humoral immune signatures in the spleens, which help understand differential host immune responses during acute scrub typhus.
- 23 April 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1791779
Open AccessDifferential spleen immune signatures and germinal center responses during acute infection with Orientia tsutsugamushi Karp versus Gilliam strains
Introduction: Scrub typhus is an emerging and neglected tropical disease caused by Orientia tsutsugamushi ( Ot ). Immunity in scrub typhus patients is known to be short-lived; however, its underlying mechanisms remain unclear. No reports have examined humoral immune signatures to clinically prevalent Ot strains. Methods: We compared two clinically relevant Ot strains, Karp and Gilliam, in a C57BL/6 murine model. Using equivalent infectious doses, we assessed splenic B cell and germinal center (GC) responses during acute infection through flow cytometry, immunohistology, serological analyses, and RNA sequencing. Results: Karp infection resulted in high tissue bacterium burdens and 50% mortality rates, whereas Gilliam infection was self-healing with limited bacterium dissemination and growth. Yet, Gilliam induced strong splenic B cell responses, as judged by total numbers of B cells, follicular B cells, and marginal zone B cells, which correlated with serum IgG and IgM levels. Given that Karp- but not Gilliam-infected spleens displayed GC disorganization/loss and MZ abrogation, we compared splenic RNAseq profiles. On day 4 post-infection, Karp induced significant elevation of transcriptional inflammatory signatures ( Ccl2 , Il33 , Ifng ) and inflammatory gene pathways ( Il1 , Il6 , Tnf , Ifng ), the characteristics of severe scrub typhus. Moreover, IPA analysis revealed Karp-induced neutrophil activation/degranulation and defense response pathways, which were in sharp contrast to Gilliam-induced upregulation of phagocytosis signaling pathways. Splenocyte flow cytometry confirmed significantly higher influx of activated phagocyte subsets (neutrophils, M1 macrophages, and inflammatory monocytes) during Karp infection than Gilliam infection, indicating greater infiltration of innate immune cells in severe scrub typhus. Discussion: Collectively, this study provides the first lines of evidence for Ot strain-related, cellular and humoral immune signatures in the spleens, which help understand differential host immune responses during acute scrub typhus.
- 19 June 2023
- Published by Elsevier in International Immunopharmacology
- Vol. 121, 110512
Metformin restrains ZIKV replication and alleviates virus-induced inflammatory responses in microglia
- 19 June 2023
- Published by Elsevier in International Immunopharmacology
- Vol. 121, 110512
Metformin restrains ZIKV replication and alleviates virus-induced inflammatory responses in microglia
- Open Access
- 15 March 2023
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 210 (9) , 1437-1446
A Microphysiological Device to Model the Choriodecidual Interface Immune Status during Pregnancy
During human pregnancy the chorion (fetal) lines decidua (maternal) creating the feto–maternal interface. Despite their proximity, resident decidual immune cells remain quiescent during gestation and do not invade the chorion. Infection and infiltration of activated immune cells toward the chorion are often associated with preterm birth. However, the mechanisms that maintain choriodecidual immune homeostasis or compromise immune barrier functions remain unclear. To understand these processes, a two-chamber microphysiological system (MPS) was created to model the human choriodecidual immune interface under normal and infectious conditions in vitro. This MPS has outer (fetal chorion trophoblast cells) and inner chambers (maternal decidual + CD45+ cells [70:30 ratio]) connected by microchannels. Decidual cells were treated with LPS to mimic maternal infection, followed by immunostaining for HLA-DR and HLA-G, immune panel screening by imaging cytometry by time of flight, and immune regulatory factors IL-8 and IL-10, soluble HLA-G, and progesterone (ELISA). LPS induced a proinflammatory phenotype in the decidua characterized by a decrease in HLA-DR and an increase in IL-8 compared with controls. LPS treatment increased the influx of immune cells into the chorion, indicative of chorionitis. Cytometry by time of flight characterized immune cells in both chambers as active NK cells and neutrophils, with a decrease in the abundance of nonproinflammatory cytokine-producing NK cells and T cells. Conversely, chorion cells increased progesterone and soluble HLA-G production while maintaining HLA-G expression. These results highlight the utility of MPS to model choriodecidual immune cell infiltration and determine the complex maternal–fetal crosstalk to regulate immune balance during infection.
- 15 March 2023
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 210 (9) , 1437-1446
Open AccessA Microphysiological Device to Model the Choriodecidual Interface Immune Status during Pregnancy
During human pregnancy the chorion (fetal) lines decidua (maternal) creating the feto–maternal interface. Despite their proximity, resident decidual immune cells remain quiescent during gestation and do not invade the chorion. Infection and infiltration of activated immune cells toward the chorion are often associated with preterm birth. However, the mechanisms that maintain choriodecidual immune homeostasis or compromise immune barrier functions remain unclear. To understand these processes, a two-chamber microphysiological system (MPS) was created to model the human choriodecidual immune interface under normal and infectious conditions in vitro. This MPS has outer (fetal chorion trophoblast cells) and inner chambers (maternal decidual + CD45+ cells [70:30 ratio]) connected by microchannels. Decidual cells were treated with LPS to mimic maternal infection, followed by immunostaining for HLA-DR and HLA-G, immune panel screening by imaging cytometry by time of flight, and immune regulatory factors IL-8 and IL-10, soluble HLA-G, and progesterone (ELISA). LPS induced a proinflammatory phenotype in the decidua characterized by a decrease in HLA-DR and an increase in IL-8 compared with controls. LPS treatment increased the influx of immune cells into the chorion, indicative of chorionitis. Cytometry by time of flight characterized immune cells in both chambers as active NK cells and neutrophils, with a decrease in the abundance of nonproinflammatory cytokine-producing NK cells and T cells. Conversely, chorion cells increased progesterone and soluble HLA-G production while maintaining HLA-G expression. These results highlight the utility of MPS to model choriodecidual immune cell infiltration and determine the complex maternal–fetal crosstalk to regulate immune balance during infection.
- Top Cited PapersOpen Access
- 14 September 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 14 (662) , eabq1945
Dual spike and nucleocapsid mRNA vaccination confer protection against SARS-CoV-2 Omicron and Delta variants in preclinical models
Emergence of SARS-CoV-2 variants of concern (VOCs), including the highly transmissible Omicron and Delta strains, has posed constant challenges to the current COVID-19 vaccines that principally target the viral spike protein (S). Here, we report a nucleoside-modified messenger RNA (mRNA) vaccine that expresses the more conserved viral nucleoprotein (mRNA-N) and show that mRNA-N vaccination alone can induce modest control of SARS-CoV-2. Critically, combining mRNA-N with the clinically proven S-expressing mRNA vaccine (mRNA-S+N) induced robust protection against both Delta and Omicron variants. In the hamster models of SARS-CoV-2 VOC challenge, we demonstrated that, compared to mRNA-S alone, combination mRNA-S+N vaccination not only induced more robust control of the Delta and Omicron variants in the lungs but also provided enhanced protection in the upper respiratory tract. In vivo CD8 + T cell depletion suggested a potential role for CD8 + T cells in protection conferred by mRNA-S+N vaccination. Antigen-specific immune analyses indicated that N-specific immunity, as well as augmented S-specific immunity, was associated with enhanced protection elicited by the combination mRNA vaccination. Our findings suggest that combined mRNA-S+N vaccination is an effective approach for promoting broad protection against SARS-CoV-2 variants.
- 14 September 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 14 (662) , eabq1945
Top Cited PapersOpen AccessDual spike and nucleocapsid mRNA vaccination confer protection against SARS-CoV-2 Omicron and Delta variants in preclinical models
Emergence of SARS-CoV-2 variants of concern (VOCs), including the highly transmissible Omicron and Delta strains, has posed constant challenges to the current COVID-19 vaccines that principally target the viral spike protein (S). Here, we report a nucleoside-modified messenger RNA (mRNA) vaccine that expresses the more conserved viral nucleoprotein (mRNA-N) and show that mRNA-N vaccination alone can induce modest control of SARS-CoV-2. Critically, combining mRNA-N with the clinically proven S-expressing mRNA vaccine (mRNA-S+N) induced robust protection against both Delta and Omicron variants. In the hamster models of SARS-CoV-2 VOC challenge, we demonstrated that, compared to mRNA-S alone, combination mRNA-S+N vaccination not only induced more robust control of the Delta and Omicron variants in the lungs but also provided enhanced protection in the upper respiratory tract. In vivo CD8 + T cell depletion suggested a potential role for CD8 + T cells in protection conferred by mRNA-S+N vaccination. Antigen-specific immune analyses indicated that N-specific immunity, as well as augmented S-specific immunity, was associated with enhanced protection elicited by the combination mRNA vaccination. Our findings suggest that combined mRNA-S+N vaccination is an effective approach for promoting broad protection against SARS-CoV-2 variants.
- Open Access
- 19 January 2022
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 208 (4) , 861-869
The Protective Role of IL-36/IL-36R Signal in Con A–Induced Acute Hepatitis
The IL-36 family, including IL-36α, IL-36β, IL-36γ, and IL-36R antagonist, belong to the IL-1 superfamily. It was reported that IL-36 plays a role in immune diseases. However, it remains unclear how IL-36 regulates inflammation. To determine the role of IL-36/IL-36R signaling pathways, we established an acute hepatitis mouse model (C57BL/6) by i.v. injection of the plant lectin Con A. We found that the levels of IL-36 were increased in the liver after Con A injection. Our results demonstrated the infiltrated neutrophils, but not the hepatocytes, were the main source of IL-36 in the liver. Using the IL-36R−/− mouse model (H-2b), we surprisingly found that the absence of IL-36 signals led to aggravated liver injury, as evidenced by increased mortality, elevated serum alanine aminotransferase and aspartate aminotransferase levels, and severe liver pathological changes. Further investigations demonstrated that a lack of IL-36 signaling induced intrahepatic activation of CD4+ and CD8+ T lymphocytes and increased the production of inflammatory cytokines. In addition, IL-36R−/− mice had reduced T regulatory cell numbers and chemokines in the liver. Together, our results from the mouse model suggested a vital role of IL-36 in regulating T cell function and homeostasis during liver inflammation.
- 19 January 2022
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 208 (4) , 861-869
Open AccessThe Protective Role of IL-36/IL-36R Signal in Con A–Induced Acute Hepatitis
The IL-36 family, including IL-36α, IL-36β, IL-36γ, and IL-36R antagonist, belong to the IL-1 superfamily. It was reported that IL-36 plays a role in immune diseases. However, it remains unclear how IL-36 regulates inflammation. To determine the role of IL-36/IL-36R signaling pathways, we established an acute hepatitis mouse model (C57BL/6) by i.v. injection of the plant lectin Con A. We found that the levels of IL-36 were increased in the liver after Con A injection. Our results demonstrated the infiltrated neutrophils, but not the hepatocytes, were the main source of IL-36 in the liver. Using the IL-36R−/− mouse model (H-2b), we surprisingly found that the absence of IL-36 signals led to aggravated liver injury, as evidenced by increased mortality, elevated serum alanine aminotransferase and aspartate aminotransferase levels, and severe liver pathological changes. Further investigations demonstrated that a lack of IL-36 signaling induced intrahepatic activation of CD4+ and CD8+ T lymphocytes and increased the production of inflammatory cytokines. In addition, IL-36R−/− mice had reduced T regulatory cell numbers and chemokines in the liver. Together, our results from the mouse model suggested a vital role of IL-36 in regulating T cell function and homeostasis during liver inflammation.
- 19 August 2021
- Published by Wiley in Immunology
- Vol. 165 (1) , 61-73
IL‐33 activates mTORC1 and modulates glycolytic metabolism in CD8+ T cells
Interleukin (IL)‐33, a member in the IL‐1 family, plays a central role in innate and adaptive immunity; however, how IL‐33 mediates cytotoxic T‐cell regulation and the downstream signals remain elusive. In this study, we found increased mouse IL‐33 expression in CD8+ T cells following cell activation via anti‐CD3/CD28 stimulation in vitro or lymphocytic choriomeningitis virus (LCMV) infection in vivo. Our cell adoptive transfer experiment demonstrated that extracellular, but not nuclear, IL‐33 contributed to the activation and proliferation of CD8+, but not CD4+ T effector cells in LCMV infection. Importantly, IL‐33 induced mTORC1 activation in CD8+ T cells as evidenced by increased phosphorylated S6 ribosomal protein (p‐S6) levels both in vitro and in vivo. Meanwhile, this IL‐33‐induced CD8+ T‐cell activation was suppressed by mTORC1 inhibitors. Furthermore, IL‐33 elevated glucose uptake and lactate production in CD8+ T cells in both dose‐ and time‐dependent manners. The results of glycolytic rate assay demonstrated the increased glycolytic capacity of IL‐33‐treated CD8+ T cells compared with that of control cells. Our mechanistic study further revealed the capacity of IL‐33 in promoting the expression of glucose transporter 1 (Glut1) and glycolytic enzymes via mTORC1, leading to accelerated aerobic glucose metabolism Warburg effect and increased effector T‐cell activation. Together, our data provide new insights into IL‐33‐mediated regulation of CD8+ T cells, which might be beneficial for therapeutic strategies of inflammatory and infectious diseases in the future.
- 19 August 2021
- Published by Wiley in Immunology
- Vol. 165 (1) , 61-73
IL‐33 activates mTORC1 and modulates glycolytic metabolism in CD8+ T cells
Interleukin (IL)‐33, a member in the IL‐1 family, plays a central role in innate and adaptive immunity; however, how IL‐33 mediates cytotoxic T‐cell regulation and the downstream signals remain elusive. In this study, we found increased mouse IL‐33 expression in CD8+ T cells following cell activation via anti‐CD3/CD28 stimulation in vitro or lymphocytic choriomeningitis virus (LCMV) infection in vivo. Our cell adoptive transfer experiment demonstrated that extracellular, but not nuclear, IL‐33 contributed to the activation and proliferation of CD8+, but not CD4+ T effector cells in LCMV infection. Importantly, IL‐33 induced mTORC1 activation in CD8+ T cells as evidenced by increased phosphorylated S6 ribosomal protein (p‐S6) levels both in vitro and in vivo. Meanwhile, this IL‐33‐induced CD8+ T‐cell activation was suppressed by mTORC1 inhibitors. Furthermore, IL‐33 elevated glucose uptake and lactate production in CD8+ T cells in both dose‐ and time‐dependent manners. The results of glycolytic rate assay demonstrated the increased glycolytic capacity of IL‐33‐treated CD8+ T cells compared with that of control cells. Our mechanistic study further revealed the capacity of IL‐33 in promoting the expression of glucose transporter 1 (Glut1) and glycolytic enzymes via mTORC1, leading to accelerated aerobic glucose metabolism Warburg effect and increased effector T‐cell activation. Together, our data provide new insights into IL‐33‐mediated regulation of CD8+ T cells, which might be beneficial for therapeutic strategies of inflammatory and infectious diseases in the future.
- 10 May 2021
- Published by Springer Nature in Cellular & Molecular Immunology
- Vol. 18 (6) , 1602-1604
IL-33 in COVID-19: friend or foe?
- 10 May 2021
- Published by Springer Nature in Cellular & Molecular Immunology
- Vol. 18 (6) , 1602-1604
IL-33 in COVID-19: friend or foe?
- Open Access
- 21 April 2021
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 12
Metformin Modulates T Cell Function and Alleviates Liver Injury Through Bioenergetic Regulation in Viral Hepatitis
Metformin is not only the first-line medication for the treatment of type 2 diabetes, but it is also effective as an anti-inflammatory, anti-oxidative and anti-tumor agent. However, the effect of metformin during viral hepatitis remains elusive. Using an adenovirus (Ad)-induced viral hepatitis mouse model, we found that metformin treatment significantly attenuated liver injury, with reduced serum aspartate transaminase (AST) and alanine transaminase (ALT) levels and liver histological changes, presumably via decreased effector T cell responses. We then demonstrated that metformin reduced mTORC1 activity in T cells from infected mice, as evidenced by decreased phosphorylation of ribosome protein S6 (p-S6). The inhibitory effects on the mTORC1 signaling by metformin was dependent on the tuberous sclerosis complex 1 (TSC1). Mechanistically, metformin treatment modulated the phosphorylation of dynamin-related protein 1 (Drp-1) and mitochondrial fission 1 protein (FIS1), resulting in increased mass in effector T cells. Moreover, metformin treatment promoted mitochondrial superoxide production, which can inhibit excessive T cell activation in viral hepatitis. Together, our results revealed a protective role and therapeutic potential of metformin against liver injury in acute viral hepatitis via modulating effector T cell activation via regulating the mTORC1 pathway and mitochondrial functions.
- 21 April 2021
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 12
Open AccessMetformin Modulates T Cell Function and Alleviates Liver Injury Through Bioenergetic Regulation in Viral Hepatitis
Metformin is not only the first-line medication for the treatment of type 2 diabetes, but it is also effective as an anti-inflammatory, anti-oxidative and anti-tumor agent. However, the effect of metformin during viral hepatitis remains elusive. Using an adenovirus (Ad)-induced viral hepatitis mouse model, we found that metformin treatment significantly attenuated liver injury, with reduced serum aspartate transaminase (AST) and alanine transaminase (ALT) levels and liver histological changes, presumably via decreased effector T cell responses. We then demonstrated that metformin reduced mTORC1 activity in T cells from infected mice, as evidenced by decreased phosphorylation of ribosome protein S6 (p-S6). The inhibitory effects on the mTORC1 signaling by metformin was dependent on the tuberous sclerosis complex 1 (TSC1). Mechanistically, metformin treatment modulated the phosphorylation of dynamin-related protein 1 (Drp-1) and mitochondrial fission 1 protein (FIS1), resulting in increased mass in effector T cells. Moreover, metformin treatment promoted mitochondrial superoxide production, which can inhibit excessive T cell activation in viral hepatitis. Together, our results revealed a protective role and therapeutic potential of metformin against liver injury in acute viral hepatitis via modulating effector T cell activation via regulating the mTORC1 pathway and mitochondrial functions.
- Open Access
- 25 August 2020
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 17 (1) , 1-13
IL-22 hinders antiviral T cell responses and exacerbates ZIKV encephalitis in immunocompetent neonatal mice
Background: The Zika virus (ZIKV) outbreak that occurred in multiple countries was linked to increased risk of nervous system injuries and congenital defects. However, host immunity- and immune-mediated pathogenesis in ZIKV infection are not well understood. Interleukin-22 (IL-22) is a crucial cytokine for regulating host immunity in infectious diseases. Whether IL-22 plays, a role in ZIKV infection is unknown. Methods: The cellular source of IL-22 was identified in IFNAR-/- mice and wild-type (WT) neonatal mice during ZIKV infection. To determine the role of IL-22, we challenged 1-day-old WT and IL-22-/- mice with ZIKV and monitored clinical manifestations. Glial cell activation in the brain was assessed by confocal imaging. ZIKV-specific CD8+ T cell responses in both the spleen and brain were analyzed by flow cytometry. In addition, glial cells were cultured in vitro and infected with ZIKV in the presence of IL-22, followed by the evaluation of cell proliferation, cytokine expression, and viral loads. Results: We found that γδ T cells were the main source of IL-22 during ZIKV infection in both the spleen and brain. WT mice began to exhibit weight loss, staggered steps, bilateral hind limb paralysis, and weakness at 10 days post-infection (dpi) and ultimately succumbed to infection at 16–19 dpi. IL-22 deficiency lessened weight loss, moderated the systemic inflammatory response, and greatly improved clinical signs of neurological disease and mortality. ZIKV infection also induced the activation of microglia and astrocytes in vitro. Additional analysis demonstrated that the absence of IL-22 resulted in reduced activation of microglia and astrocytes in the cortex. Although IL-22 displayed a negligible effect on glial cells in vitro, IL-22-/- mice mounted more vigorous ZIKV-specific CD8+ T cell responses, which led to a more effective control of ZIKV in the brain. Conclusions: Our data revealed a pathogenic role of IL-22 in ZIKV encephalitis.
- 25 August 2020
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 17 (1) , 1-13
Open AccessIL-22 hinders antiviral T cell responses and exacerbates ZIKV encephalitis in immunocompetent neonatal mice
Background: The Zika virus (ZIKV) outbreak that occurred in multiple countries was linked to increased risk of nervous system injuries and congenital defects. However, host immunity- and immune-mediated pathogenesis in ZIKV infection are not well understood. Interleukin-22 (IL-22) is a crucial cytokine for regulating host immunity in infectious diseases. Whether IL-22 plays, a role in ZIKV infection is unknown. Methods: The cellular source of IL-22 was identified in IFNAR-/- mice and wild-type (WT) neonatal mice during ZIKV infection. To determine the role of IL-22, we challenged 1-day-old WT and IL-22-/- mice with ZIKV and monitored clinical manifestations. Glial cell activation in the brain was assessed by confocal imaging. ZIKV-specific CD8+ T cell responses in both the spleen and brain were analyzed by flow cytometry. In addition, glial cells were cultured in vitro and infected with ZIKV in the presence of IL-22, followed by the evaluation of cell proliferation, cytokine expression, and viral loads. Results: We found that γδ T cells were the main source of IL-22 during ZIKV infection in both the spleen and brain. WT mice began to exhibit weight loss, staggered steps, bilateral hind limb paralysis, and weakness at 10 days post-infection (dpi) and ultimately succumbed to infection at 16–19 dpi. IL-22 deficiency lessened weight loss, moderated the systemic inflammatory response, and greatly improved clinical signs of neurological disease and mortality. ZIKV infection also induced the activation of microglia and astrocytes in vitro. Additional analysis demonstrated that the absence of IL-22 resulted in reduced activation of microglia and astrocytes in the cortex. Although IL-22 displayed a negligible effect on glial cells in vitro, IL-22-/- mice mounted more vigorous ZIKV-specific CD8+ T cell responses, which led to a more effective control of ZIKV in the brain. Conclusions: Our data revealed a pathogenic role of IL-22 in ZIKV encephalitis.
- Open Access
- 13 April 2020
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 204 (11) , 2984-2994
Retinoic Acid Modulates Hyperactive T Cell Responses and Protects Vitamin A–Deficient Mice against Persistent Lymphocytic Choriomeningitis Virus Infection
Vitamin A deficiency (VAD) is a major public health problem and is associated with increased host susceptibility to infection; however, how VAD influences viral infection remains unclear. Using a persistent lymphocytic choriomeningitis virus infection model, we showed in this study that although VAD did not alter innate type I IFN production, infected VAD mice had hyperactive, virus-specific T cell responses at both the acute and contraction stages, showing significantly decreased PD-1 but increased cytokine (IFN-γ, TNF-α, and IL-2) expression by T cells. Compared with control mice, VAD mice displayed excessive inflammation and more severe liver pathology, with increased death during persistent infection. Of note, supplements of all-trans retinoic acid (RA), one of the important metabolites of vitamin A, downregulated hyperactive T cell responses and rescued the persistently infected VAD mice. By using adoptive transfer of splenocytes, we found that the environmental vitamin A or its metabolites acted as rheostats modulating antiviral T cells. The analyses of T cell transcriptional factors and signaling pathways revealed the possible mechanisms of RA, as its supplements inhibited the abundance of NFATc1 (NFAT 1), a key regulator for T cell activation. Also, following CD3/CD28 cross-linking stimulation, RA negatively regulated the TCR-proximal signaling in T cells, via decreased phosphorylation of Zap70 and its downstream signals, including phosphorylated AKT, p38, ERK, and S6, respectively. Together, our data reveal VAD-mediated alterations in antiviral T cell responses and highlight the potential utility of RA for modulating excessive immune responses and tissue injury in infectious diseases.
- 13 April 2020
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 204 (11) , 2984-2994
Open AccessRetinoic Acid Modulates Hyperactive T Cell Responses and Protects Vitamin A–Deficient Mice against Persistent Lymphocytic Choriomeningitis Virus Infection
Vitamin A deficiency (VAD) is a major public health problem and is associated with increased host susceptibility to infection; however, how VAD influences viral infection remains unclear. Using a persistent lymphocytic choriomeningitis virus infection model, we showed in this study that although VAD did not alter innate type I IFN production, infected VAD mice had hyperactive, virus-specific T cell responses at both the acute and contraction stages, showing significantly decreased PD-1 but increased cytokine (IFN-γ, TNF-α, and IL-2) expression by T cells. Compared with control mice, VAD mice displayed excessive inflammation and more severe liver pathology, with increased death during persistent infection. Of note, supplements of all-trans retinoic acid (RA), one of the important metabolites of vitamin A, downregulated hyperactive T cell responses and rescued the persistently infected VAD mice. By using adoptive transfer of splenocytes, we found that the environmental vitamin A or its metabolites acted as rheostats modulating antiviral T cells. The analyses of T cell transcriptional factors and signaling pathways revealed the possible mechanisms of RA, as its supplements inhibited the abundance of NFATc1 (NFAT 1), a key regulator for T cell activation. Also, following CD3/CD28 cross-linking stimulation, RA negatively regulated the TCR-proximal signaling in T cells, via decreased phosphorylation of Zap70 and its downstream signals, including phosphorylated AKT, p38, ERK, and S6, respectively. Together, our data reveal VAD-mediated alterations in antiviral T cell responses and highlight the potential utility of RA for modulating excessive immune responses and tissue injury in infectious diseases.